“…Unfortunately, passive targeting via enhanced permeability and retention effect (EPR) is often insufficient, so researchers additionally apply various targeting ligands to ensure a sufficient accumulation and antitumor effect, such as antibodies, growth factors, transferrin, alpha-fetoprotein, cytokines, folic acid, low-density lipoprotein, tumor proteases, and tumor matrix proteins [ 16 , 17 , 18 , 19 ].…”